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Abstract
Cytolethal distending toxins (Cdt) are a family of toxins produced by several human pathogens which
infect mucocutaneous tissue and induce inflammatory disease. We have previously demonstrated that
the Aggregatibacter actinomycetemcomitans Cdt induces a pro-inflammatory response from human
macrophages which involves activation of the NLRP3 inflammasome. We now demonstrate that in
addition to activating caspase-1 (canonical inflammasome), Cdt treatment leads to caspase-4 activation
and involvement of the noncanonical inflammasome. Cdt-treated cells exhibit pyroptosis characterised by
cleavage of gasdermin-D (GSDMD), release of HMGB1 at 24 hr and LDH at 48 hr. Inhibition of either the
canonical (caspase-1) or noncanonical (caspase-4) inflammasome blocks both Cdt-induced release of
IL-1β and induction of pyroptosis. Analysis of upstream events indicates that Cdt induces Syk
phosphorylation (activation); furthermore, blockade of Syk expression and inhibition of pSyk activity
inhibit both Cdt-induced cytokine release and pyroptosis. Finally, we demonstrate that increases in pSyk
are dependent upon Cdt-induced activation of GSK3β. These studies advance our understanding of Cdt
function and provide new insight into the virulence potential of Cdt in mediating the pathogenesis of
disease caused by Cdt-producing organisms such as A. actinomycetemcomitans. © 2020 John Wiley &
Sons Ltd

Keywords
Aggregatibacter actinomycetemcomitans; inflammasome; mechanism of action; microbial–cell
interaction; toxins

Disciplines
Dentistry

Author(s)
Bruce J. Shenker, Lisa M. Walker, Zeyed Zekavat, David C. Ojcius, Pei-Rong Huang, and Kathleen BoeszeBattaglia

This journal article is available at ScholarlyCommons: https://repository.upenn.edu/dental_papers/413

Revised: 9 January 2020

Accepted: 24 January 2020

DOI: 10.1111/cmi.13194

RESEARCH ARTICLE
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by human macrophages is dependent upon activation of
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the noncanonical inflammasome
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pathogens which infect mucocutaneous tissue and induce inflammatory disease.
We have previously demonstrated that the Aggregatibacter actinomycetemcomitans
Cdt induces a pro-inflammatory response from human macrophages which involves
activation of the NLRP3 inflammasome. We now demonstrate that in addition to
activating caspase-1 (canonical inflammasome), Cdt treatment leads to caspase-4
activation and involvement of the noncanonical inflammasome. Cdt-treated cells
exhibit pyroptosis characterised by cleavage of gasdermin-D (GSDMD), release of
HMGB1 at 24 hr and LDH at 48 hr. Inhibition of either the canonical (caspase-1) or
noncanonical (caspase-4) inflammasome blocks both Cdt-induced release of IL-1β
and induction of pyroptosis. Analysis of upstream events indicates that Cdt induces
Syk phosphorylation (activation); furthermore, blockade of Syk expression and
inhibition of pSyk activity inhibit both Cdt-induced cytokine release and
pyroptosis. Finally, we demonstrate that increases in pSyk are dependent upon
Cdt-induced activation of GSK3β. These studies advance our understanding of Cdt
function and provide new insight into the virulence potential of Cdt in mediating
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the pathogenesis of disease caused by Cdt-producing organisms such as
A. actinomycetemcomitans.
KEYWORDS
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I N T RO DU CT I O N

Reno, & Blanke, 2012; Ge et al., 2005; Ge et al., 2007; Ge et al., 2017;
Haghjoo & Galan, 2004; Jinadasa, Bloom, Weiss, & Duhamel, 2011;

Cytolethal distending toxins (Cdt) represent a family of heat-labile

Lara-Tejero & Galan, 2001; Scuron, Boesze-Battaglia, Dlakic, &

protein cytotoxins produced by over 30 γ- and ε-Proteobacteria that

Shenker, 2016; Shenker et al., 1999; Thelestam & Frisan, 2004; Whit-

are human and/or animal pathogens. These bacteria share the com-

ehouse et al., 1998; Young et al., 2004). Moreover, Cdt-producing

mon ability to colonise mucocutaneous tissue such as oral, gastroin-

bacteria are known to induce disease in these mucocutaneous niches

testinal, urinary and respiratory tracts (DiRienzo, 2014a, 2014b; Gargi,

that are characterised by sustained infection and inflammation.

Cellular Microbiology. 2020;22:e13194.
https://doi.org/10.1111/cmi.13194
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Collectively, our studies have demonstrated that Cdt, produced by the
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RE SU LT S

periodontal pathogen, Aggregatibacter actinomycetemcomitans, is
capable of impairing lymphocyte proliferation and survival while also
promoting production of pro-inflammatory mediators from macro-

2.1 | Cdt activates the noncanonical
inflammasome leading to pyroptosis

phages (Shenker et al., 1999; Shenker et al., 2001; Shenker et al.,
2005; Shenker et al., 2015; Shenker, Demuth, & Zekavat, 2006;

The goal of this study was to explore the contribution of noncanonical

Shenker, Hoffmaster, McKay, & Demuth, 2000; Shenker, Walker,

inflammasome

Zekavat, Dlakic, & Boesze-Battaglia, 2014). Moreover, we have shown

inflammatory response in human macrophages derived from both

that these toxic effects are dependent upon the active Cdt subunit,

THP-1 cells and monocyte-derived macrophages (MDM). In this

CdtB, and its ability to function as a phosphatidylinositol (PI)-3,-

regard, the most studied mediator of the noncanonical inflammasome

4,5-triphosphate (PIP3) phosphatase which depletes cells of PIP3 and

is caspase-11 in murine macrophages and caspase-4 (and -5), the

induces blockade of the PI-3K signalling pathway (Shenker, Boesze-

human analog of caspase-11. Therefore, we focused our study on

Battaglia, Alexander, Dlakic, & Shenker, 2016; Shenker et al., 2007;

caspase-4 in macrophages derived from the human leukaemia mono-

Shenker, Walker, Zekavat, & Boesze-Battaglia, 2016b; Shenker

cytic cell line (wild type), THP-1WT. THP-1WT-derived macrophages

et al., 2014).

were treated with 0–500 ng/mL Cdt for 2 hr and the cells analysed

Cdt is a heterotrimeric complex that functions as an AB2 toxin;

pathways

in

mediating

the

Cdt-induced

pro-

for caspase-4 activation (Figure 1a). Caspase 4 activity was monitored

in addition to CdtB, the toxin consists of two additional subunits,

by measuring the net change in OD405 resulting from the release of

CdtA and CdtC, that are involved in toxin-host cell interactions

the chromophore p-NA from LEVD–pNA as described in Materials

(reviewed in (Gargi et al., 2012; Scuron et al., 2016). These interac-

and Methods. Caspase-4 activity exhibited a statistically significant

tions are dependent upon CdtC (and CdtB) binding to cholesterol

dose-dependent increase over baseline levels representing increases

within the plasma membrane (Boesze-Battaglia et al., 2009; Boesze-

of 44%, 67% and 89% in the presence of 50, 200 and 500 ng/mL Cdt,

Battaglia et al., 2015; Boesze-Battaglia et al., 2016; Boesze-Battaglia

respectively. The magnitude of the increase in caspase-4 activity was

et al., 2017; Guerra et al., 2005; Lai et al., 2013; Zhou, Zhang,

comparable to the increment observed with LPS transfection

Zhao, & Jin, 2012). As noted above, internalisation of CdtB leads to

(Figure 1s).

PI-3K signalling blockade within 2 hr in both lymphocytes and mac-

In order to determine if the increase in caspase-4 activity was

rophages (Shenker, Boesze-Battaglia et al., 2016; Shenker et al.,

critical to Cdt-induced release of mature IL-1β, THP-1WT macro-

2007; Shenker et al., 2014). Toxin-treated lymphocytes undergo cell

phages were pre-treated with 0–10 μM of the cell permeable

cycle arrest (G2/M) and apoptosis. In contrast, Cdt-mediated PI-3K

caspase-4 inhibitor (LEVD-CHO) (Figure 1b). In the presence of

blockade in non-proliferating cells such as macrophages does not

50 ng/mL Cdt, IL-1β levels increased to 441 ± 46 pg/mL versus 41.7

lead to apoptosis; instead, the toxin induces a pro-inflammatory

± 2.9 pg/mL in untreated cells. Pre-treatment of macrophages with

cytokine response. This response includes increased synthesis and

0.1, 1.0 and 10 μM inhibitor reduced IL-1β release to 54%, 41% and

release of TNFα and IL-6 as well as synthesis, maturation and release

29% of levels observed with Cdt alone. The requirement for caspase-

of IL-1β and IL-18 (Shenker et al., 2014). Recently, we also demon-

4 in mediating Cdt-induced release of IL-1β was also assessed in

strated that Cdt-mediated maturation and release of IL-1β and IL-18

MDM; as shown in Figure 1b, 200 ng/mL Cdt-induced an increase in

were dependent upon activation of the NLRP3 inflammasome which

IL-1β release to 108.8 ± 19.7 pg/mL over baseline levels of 0.2

in turn requires Cdt-dependent increases in extracellular ATP, acti-

± 0.2 pg/mL. In the presence of 0.1, 1.0 and 10 μM caspase-4 inhibi-

vation of the P2X7 purinergic receptor and K+ efflux (Shenker

tor the amount of cytokine release was significantly reduced to <20%

et al., 2015).

of levels observed in cells treated with toxin alone.

Recent studies have demonstrated that release of mature IL-1β is

To rule out possible off-target effects of the caspase-4 inhibitor

not only regulated by canonical inflammasomes which involves

and more directly implicate caspase-4 in the pro-inflammatory

caspase-1 activation, but can also involve stimulation of noncanonical

response to Cdt, THP-1 cells deficient in caspase-4 expression (THP-

inflammasomes leading to activation of other caspases such as

1Casp4-) were assessed for their susceptibility to Cdt-induced release

caspase-4 and caspase-5 (caspase-11 in mice; Platnich & Muruve,

of IL-1β. As shown in Figure 1c(inset), Western blot analysis of the

2019; Vigano et al., 2015). In light of these observations, we extended

protein levels of caspase-4 were not detectable in the THP-1Casp4-

our studies on the pro-inflammatory effects of Cdt on macrophages

cells; in contrast, caspase-4 was present in THP-1WT cells. Cells were

and now report that Cdt-induced IL-1β release is also dependent upon

then treated with Cdt for 5 hr and the supernatants analysed for IL-1β

caspase-4 activation. Furthermore, we demonstrate that Cdt-

levels by ELISA. THP-1WT macrophages exhibited a dose-dependent

mediated activation of both the canonical and noncanonical

increase in IL-1β release when challenged with 8, 40 and 200 ng/mL

inflammasome is regulated upstream by activation of spleen tyrosine

Cdt. In contrast, THPCasp4- cells were severely impaired in their ability

kinase (Syk) and GSK3β. Activation of both inflammasomes leads

to produce mature IL-1β as they released 48.9 ± 13.5, 72.0 ± 26.1

downstream to pyroptosis exemplified by the release of both the high

and 65.2 ± 12.4 pg/mL in the presence of 8, 40 and 200 ng/mL Cdt,

mobility group box 1 protein (HMGB1) and lactic dehydrogenase

respectively. It should be noted that caspase-4 deficient cells retained

(LDH) along with cleavage of gasdermin D (GSDMD).

the capacity to exhibit canonical inflammasome activation in response
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F I G U R E 1 Cdt-induced release of IL-1β is
dependent upon caspase-4 activation.
(A) THP-1WT-derived macrophages were
treated with Cdt and analysed for caspase-4
activation. Results are plotted as Cdt
concentration vs caspase-4 activity (net
OD405) and are the mean ± SEM of four
experiments. (B) THP-1WT-(circle) and
monocyte (square)-derived macrophages were
pre-treated with varying amounts of the
caspase-4 inhibitor LEVD-CHO followed by
the addition of 200 ng/mL Cdt. Supernatants
were harvested 5 hr later and analysed for IL1β by ELISA. Results are plotted as mean
± SEM pg/ml IL-1β vs caspase-4 inhibitor
concentration. Results are the mean of three
experiments; note: samples receiving caspase4 inhibitor were significantly lower at all
concentrations than samples receiving Cdt
alone (p < .05). (C) Macrophages derived from
THP-1WT (solid bar), THP-1shctrl (hatched bars)
and THP-1Casp4- (cross-hatched bars) were
treated with varying concentrations of Cdt for
5 hr. Supernatants were harvested and
analysed by ELISA for IL-1β. Results are
plotted as the mean ± SEM pg/ml IL-1β for
four experiments versus Cdt concentration.
Inset shows caspase-4 protein levels (Western
blot) in cell extracts obtained from THP-1WT,
THP-1shctrl and THP-1Casp4- derived
macrophages. The asterisk indicates statistical
significance (p < .05 relative to THP-1WTderived macrophages treated with the same
concentration of Cdt

(a)

(b)

(c)

to Cdt as previously reported (Shenker et al., 2015); Cdt-treated THP-

series of experiments, we focused on the relationship between Cdt,

1Casp4- derived macrophages demonstrated both an increase in pro-IL-

caspase-4 activation, pyroptosis and ultimately the release of cyto-

1β and active caspase-1 (p20) in response to Cdt treatment

kines. First, we assessed Cdt's ability to induce the release of LDH

(Figure 2s).

and HMGB1. THP-1WT derived macrophages were treated with Cdt

Our observations demonstrate that Cdt-induced release of IL-1β

for 48 hr and then cell supernatants were assessed for LDH activity.

is dependent upon caspase-4 activation; this finding is significant as

As shown in Figure 2a, THP-1WT cells exhibited a 24% net increase in

this caspase is involved in not only, the noncanonical inflammasome,

the release of LDH in the presence of Cdt (50 ng/mL). It should be

but also pyroptosis, a form of inflammatory caspase-mediated lytic cell

noted that in preliminary experiments, LDH release was not observed

death (Martel, Lai, Ko, Young, & Ojcius, 2016; Taabazuing, Okondo, &

at earlier time points. In contrast, THP-1Casp4- cells exhibited a 7% net

Bachovchin, 2017; Xia, Wang, Zheng, Jiang, & Hu, 2019). In the next

increase in LDH; this was statistically significantly less than the
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retain (CdtBA163R) or lack (CdtBR117A and CdtBR144A) lipid phospha-

(a)

Net LDH Release (%)

35

tase activity; these mutants have previously been characterised and it
should be noted that the latter two mutants have also been shown to

30

be deficient in toxic activity (Shenker, Boesze-Battaglia et al., 2016).
25

Supernatants were harvested 48 hr later and assessed for LDH activity; as shown in Figure 2b, THP-1WT cells treated with Cdt containing

20

CdtBWT exhibited 23% LDH release. Cells treated with Cdt containing
the CdtBA163R mutant protein, which retains both phosphatase and

15

*

10

toxic activities, exhibited 18% LDH release; this was not statistically
different from the release observed with THP-1WT cells treated with

*

5

Cdt containing CdtBWT. In contrast, cells treated with the enzymatically deficient CdtB mutants, CdtBR117A or CdtBR144A, exhibited low

0

Casp4-

Casp1THP-1
THP-1WT THP-1

levels of LDH release which were statistically significantly lower than
the amount released by cells treated with toxin containing CdtBWT

(b)

subunit.

35

Net LDH Release (%)

In addition to LDH, supernatants were assessed for the release of
HMGB1, a pro-inflammatory mediator whose release is associated

30

with pyroptosis and often employed as a marker for the activation of
25

this process (Bui et al., 2016; Johnson et al., 2015). As shown in
Figure 3a, THP-1WT cells treated with 25 ng/mL Cdt were analysed

20

by Western blot for HMGB1. Cells exhibited a significant increase in
15

release of HMGB1 at 24 hr relative to untreated (control) cells. Furthermore, as we observed with LDH release, the release of HMGB1

10

0

was dependent upon CdtB's ability to function as a lipid phosphatase.

*

5

CdtBWT CdtBA163R CdtBR117A

Cells treated with Cdt containing the active CdtBA163R subunit

*

exhibited significant HMGB1 release; these levels were comparable to
R144A

CdtB

F I G U R E 2 Cdt-induced LDH release from macrophages.
(A) macrophages derived from THP-1WT, THP-1Casp4- and THP-1Casp1cells were incubated with 50 ng/mL Cdt; supernatants were
harvested 48 hr later and analysed for LDH activity. Results are
plotted as the net release of LDH (%) mean ± SEM obtained from four
experiments vs Cdt concentration. (B) THP-1WT-derived macrophages
were treated with 50 ng/mL Cdt containing CdtBWT, CdtBA163R,
CdtBR117A or CdtBR144A. Supernatants were obtained at 48 hr and
assayed for LDH activity. Results are plotted as in (A) and are the
mean ± SEM of four experiments. The asterisk indicates statistical
significance p < .05 when compared to respective control (0 Cdt)

the release observed with cells treated with Cdt containing CdtBWT.
In contrast, cells treated with Cdt containing the phosphatase deficient subunit, CdtBR117A, exhibited much lower levels of HMGB1
release. It should also be noted that cells treated with 25 ng/mL Cdt
containing CdtBWT also exhibited a 40% reduction in total cellular
HMGB1 (Figure S3).
The requirement for caspase-1 and caspase-4 activation leading
to the release of HMGB1 was also assessed (Figure 3b). THP-1WTderived macrophages were treated with 50 ng/mL Cdt and the supernatants analysed 24 hr later for HMGB1. Results are plotted as a percentage of HMGB1 observed in the supernatants of Cdt-treated THP1WT cells (100%); as observed above, Cdt induced a significant
increase in HMGB1 release in THP-1WT cells. In contrast, both THP1Casp1- and THP-1Casp4- cells exhibited low levels of HMGB1 in their

WT

cells. In

supernatants: 1.6 ± 3.2 and 8.6 ± 5.9% of toxin-treated THP-1WT

addition to the noncanonical inflammasome, it has been reported that

cells, respectively; these levels were not significantly higher than that

pyroptosis may also be induced by the canonical inflammasome (Shi,

observed with the untreated control cells.

amount of LDH release observed with Cdt-treated THP-1

Gao, & Shao, 2017). Therefore, LDH release was also assessed in

One of the key elements in caspase-1 and -4-mediated activation

caspase-1 deficient cells. THP-1Casp-1--derived macrophages were

of pyroptosis and the resulting release of pro-inflammatory cytokines

treated with Cdt for 48 hr and the supernatants assessed for enzy-

is the cleavage of GSDMD. Caspase-1 and caspase-4 cleavage

matic activity; these cells released 3% net LDH which was also statis-

removes the C-terminal fragment; this releases and activates the N-

tically significantly less than the amount observed with Cdt-treated

terminal fragment, GSDMD-NT. This fragment is directly responsible

THP-1WT cells.

for pore formation in the plasma membrane which in turn enhances

In another series of experiments we determined whether CdtB

cytokine release and ultimately leads to cell death as indicated by

associated lipid phosphatase activity was required to induce LDH

LDH release (Liu et al., 2016). As shown in Figure 4a,b, THP-1WT-

WT

-derived macrophages. Cells were treated with

derived macrophages treated with Cdt for 24 hr exhibited an increase

50 ng/mL Cdt containing either CdtBWT or CdtB mutant proteins that

in the GSDMD-NT fragment. The levels of GSDMD-NT increased in

release from THP-1

14625822, 2020, 7, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/cmi.13194 by University Of Pennsylvania, Wiley Online Library on [14/10/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

4 of 14

(a)

(a)

HMGB1 Release (% control)

5000

4000

3000

*

*

2000

1000

(b)
0

0

25

CdtBWT

25

CdtBR117A

25

CdtBA163R

Cdt (ng/ml)

(b)
HMGB1 Release (% control)

160
140
120
100

*
-Cdt
+Cdt

80
60

(c)

40
20
0

THP-1WT THP-1Casp1- THP-1Casp4- THP-1SykF I G U R E 3 Cdt-induced HMGB1 release from macrophages.
(A) THP-1WT-derived macrophages were incubated with Cdt
containing CdtBWT, CdtBR117A or CdtBA163R. Following incubation for
24 hr, supernatants were harvested and analysed by Western blot for
the presence of HMGB1. Results are plotted as HMGB1 levels (% of
levels released by control cells; 0 Cdt) versus Cdt concentration and
CdtB subunit type; results represent the mean ± SEM of four
experiments. A representative Western blot is shown for HGMB1.
(B) Macrophages derived from THP-1WT, THP-1Casp1-, THP-1Casp4and THP-1Syk- cells incubated with medium (solid bars) or 50 ng/mL
Cdt (hatched bars); 24 hr later, supernatants were harvested and
analysed for the presence of HMGB1. Results are plotted as HMGB1
release (% of release observed in THP-1WT-derived macrophages
incubated with Cdt) vs cell type. Results are the mean ± SEM of three
experiments. The asterisk indicates statistical significance (p < .05)
when compared to control cells incubated in medium alone (A) or to
THP-1WT-derived macrophages incubated with Cdt. A representative
full blot is shown in Figure 5s

cells treated with Cdt to 401 (50 ng/mL Cdt), 501 (100 ng/mL Cdt)
and 443 (200 ng/mL Cdt) percent over that observed with cells incubated in medium alone; these increases were statistically significant.
Further evidence of GSDMD-NT involvement in Cdt-induced cytokine release was demonstrated by its pharmacologic inhibition. NSA

F I G U R E 4 Cdt-treated macrophages exhibit GSDMD cleavage.
(A) Macrophages derived from THP-1WT cells were incubated with
varying amounts of Cdt for 24 hr. Cell extracts were analysed by
Western blot for the presence of GSDMD-NT. (A) shows a
representative blot. (B) shows the results of three experiments:
data are plotted as percent release (relative to control cells) mean
± SEM. (C) THP-1WT-derived macrophages were pre-incubated
with varying amounts of NSA for 60 min followed by the addition
of 200 ng/mL Cdt. Supernatants were analysed 5 hr later for the
presence of IL-1β by ELISA. Results are plotted as the mean ± SEM
of three experiments vs NSA concentration. The asterisk indicates
statistical significance <.05. A representative full blot is shown in
Figure 5s
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(a)

(d)

(b)

(e)

(c)

(f)

FIGURE 5

Legend on next page.
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has recently been shown to bind to GSDMD and inhibit both pore for-

significant increase (318% of control values) at 15 min; these levels

mation by GSDMD-NT and the subsequent onset of pyroptosis

continued to rise to 412% (30 min) and 917% (60 min) above control

WT

(Rathkey et al., 2018). In Figure 4c, we demonstrate that THP-1

-

derived macrophages pre-treated with 5, 10 and 20 μM NSA blocked

levels. The levels remained elevated at 120 min but lower than the
peak levels observed at 60 min (395%).

Cdt-induced release of IL-1β; in the presence of toxin alone, cells

To determine if Syk is critical to Cdt-mediated inflammasome

released 427 pg/mL cytokine. In contrast, pre-treatment with NSA

activation and the release of IL-1β, we utilised both a pharmacologic

reduced IL-1β release to 181, 0.2 and 0 pg/mL IL-1β. Furthermore,

and molecular approach to block its activation. First, three Syk inhibi-

pre-treatment with 10 μM NSA reduced LDH release from 18% with

tors were employed: Syk Inhibitor II [(Syk II); 0–100 nM], Bay61-3606

Cdt alone to 6.9% (inset, Figure 4c).

[(Bay61); 0–4 μM] and piceatanol [(pic); 0–1 μM] (Figure 5c). THP-WT-

Preparations of recombinant proteins expressed in E. coli typically

derived macrophages were pre-incubated with each inhibitor for 1 hr

contain some level of LPS contamination. While our preparations typi-

followed by the addition of 200 ng/mL Cdt; after an additional 5 hr

cally contain low levels of LPS, we routinely prepare samples of Cdt in

incubation, supernatants were collected and analysed for the pres-

which we have significantly reduced the levels of LPS (Cdt-LD). This

ence of IL-1β by ELISA. Cells treated with Cdt in the absence of inhibi-

preparation of toxin is employed in select experiments to rule out

tor released 824 ± 122 pg/mL IL-1β as compared to 108 ± 10 pg/mL

contribution of LPS contamination as a significant contributor to our

for cells exposed to medium only. Pre-treatment of cells with the low-

experimental observations. As shown in Figure S4, we compared our

est dose of each inhibitor resulted in significant reductions in IL-1β

standard Cdt preparation to Cdt-LD for their ability to activate

release: 70 ± 19, 306 ± 233 and 104 ± 38 pg/mL in the presence of

caspase-4, induce the release of both HMGB1 and LDH as well as the

Syk II inhibitor (10 nM), Bay61-3606 (1 μM) and piceatanol (0.6 μM),

cleavage of GSDMD. In each instance, we failed to detect a significant

respectively. IL-1β release continued to decline in the presence of

difference in the potency of the two Cdt preparations.

50 and 100 nM Syk II inhibitor to 67 ± 28 and 95 ± 74 pg/mL. No further decreases were observed with Bay61-3606 and piceatanol.
Lentivirus particles containing Syk shRNA sequences were used

2.2 | Upstream events critical to Cdt-induced
activation of noncanonical pyroptosis

to transfect THP-1 cells (THP-1Syk-) and reduce Syk expression
(Figure 5d, inset). These cells were employed to further analyse the
requirement for Syk in Cdt-induced IL-1β maturation and release. As

In the next series of experiments we explored the role of the non-

shown in Figure 5d, treatment of THP-1WT cells with increasing con-

receptor protein tyrosine kinase, Syk, as an upstream mediator of Cdt-

centrations of Cdt (0–200 ng/mL) resulted in a dose-dependent

induced activation of both canonical and noncanonical inflamma-

increase in the release of IL-1β into the medium: 100 ± 4.3 (0 Cdt),

somes. Cdt-treated macrophages were first assessed for changes in

318 ± 43 (8 ng/mL Cdt), 496 ± 58 (40 ng/mL Cdt) and 738 ± 29 pg/

both total Syk and its activated form, phosphorylated Syk (pSyk;

mL (200 ng/mL Cdt). In contrast, THP-1Syk- cells were severely com-

WT

525/526). THP-1

-derived macrophages were treated with Cdt

promised in their ability to respond to Cdt as these cells released

(200 ng/mL) and analysed by Western blot over time ((0–120 min);

55 (0 Cdt), 82 (8 ng/mL Cdt), 161 (40 ng/mL Cdt) and 219 pg/mL IL-

Figure 5a,b). The levels of Syk and pSyk, respectively, are presented

1β (200 ng/mL Cdt).

as a percentage of the amount of each protein observed in untreated

In addition to Cdt-induced release of IL-1β in THP-1Syk- cells, the

control cells. Total Syk levels remained relatively constant over the

release of both LDH and HMGB1 into cell supernatants was assessed.

2 hr time period. In contrast, pSyk levels exhibited a statistically

As shown in Figure 5e, the supernatants of THP-1WT cells contained

F I G U R E 5 Cdt-induced pro-inflammatory response and noncanonical inflammasome activation is dependent upon Syk. (A, B) THP-1WTderived macrophages were incubated with 200 ng/mL Cdt for 0–120 min; cell extracts were analysed for the Syk and pSyk levels by Western
blot. A representative blot including GAPDH (G) is shown in (A) and pooled results from three experiments in (B); data are plotted as a percentage
of untreated (time 0) levels and represent the mean ± SEM of four experiments. The asterisk indicates statistical significance (p < .05) when
compared to cells exposed to medium only. (C) THP-1WT-derived macrophages were pre-incubated with varying amounts of one of three Syk
inhibitors: Syk II (circle), Bay61 (triangles) or piceatannol (Pic) for 60 min followed by the addition of 200 ng/mL Cdt. Supernatants were
harvested 5 hr later and analysed by ELISA for IL-1β. Results are plotted as mean ± SEM of IL-1β (pg/ml) based on three experiments vs Syk
inhibitor concentration. Note: all samples treated with inhibitor and Cdt were statistically significantly lower when compared to cells treated with
Cdt alone. (D) Macrophages derived from THP-1WT (cross hatched bars), THP-1shctrl (hatched bars) and THP-1Syk- (solid bars) cells were incubated
with varying amounts of Cdt. Supernatants were harvested 5 hr later and analysed by ELISA for IL-1β. Results are plotted as mean ± SEM of IL-1β
(pg/ml) of three experiments vs Cdt concentration. The asterisk indicates statistical significance (p < .05) when compared to control cells (0 Cdt).
(E) THP-1WT- and THP-1Syk--derived macrophages were incubated with medium or 200 ng/mL Cdt (cross-hatched bars) for 48 hr; supernatants
were analysed for LDH activity and plotted as net LDH release (%) (mean ± SEM for four experiments). The asterisk indicates statistical
significance (p < .05) when compared to Cdt-treated THP-1WT control cells (0 Cdt). (F) THP-1WT- and THP-1Syk--derived macrophages were
incubated with medium (open bars), 200 ng/mL Cdt (hatched bars) and 500 ng/mL Cdt (solid bars) for 2 hr. Cell extracts were analysed for
caspase-4 activity (net OD405). Results are the mean ± SEM for four experiments; * indicates statistical significance when compared to control
cells (0 Cdt)
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Relative protein levels (% control)

levels observed in untreated control cells. In the presence of Cdt, pSyk
pSyk
600

levels increased to 328.8% above control cell levels. The inhibitors

Syk

levels observed with Cdt alone. Total Syk levels were not significantly

GAPDH

*

*

400

blocked the effects of Cdt on pSyk levels as they remained below
altered by either of the inhibitors.

pSYK
SYK
GAPDH

3

200

|

DI SCU SSION

Cdt toxicity is typically associated with induction of irreversible cell
0

-

+

-

-

-

+

-

+
-

+

-

+
+

+

GSK-3 Inh X
GSK-3 Inh XV
Cdt

cycle arrest and eventually apoptotic cell death in proliferating cells
such as lymphocytes (reviewed in Gargi et al., 2013; Scuron et al.,
2016). In previous studies, however, we have demonstrated that non-

F I G U R E 6 GSK3β inhibitors block Cdt-induced Syk
phosphorylation. THP-1WT-derived macrophages were pre-incubated
with medium, 10 μM GSK-3 Inh X or 1.0 μM GSK-3 Inh XV for 60.
Medium or 200 ng/mL Cdt was then added to cell cultures and cells
harvested 2 hr later. Cell extracts were analysed for Syk and pSyk by
western blot. GAPDH was used as a loading control. Results are
plotted as the relative protein levels (% control) and represent the
mean ± SEM of three experiments. A representative blot is shown in
the inset. The asterisk indicates statistical significance relative to cells
treated with medium

proliferating cells, such as human monocytes and macrophages, are
resistant

to

A.

actinomycetemcomitans

Cdt-induced

apoptosis

(Shenker et al., 2014; Shenker et al., 2015). Instead, the toxin induces
macrophages derived from either human monocytes or from the acute
monocytic leukaemia cell line, THP-1, to synthesise and release proinflammatory cytokines (IL-1β, IL-18, TNFα and IL-6). Additionally, we
have shown that the Cdt-induced pro-inflammatory response involves
activation of the canonical NLRP3 inflammasome (Figure 7). In those
studies we employed both specific inhibitors and stable transfection
(shRNA) of cell lines to demonstrate requirements for NLRP3, ASC as
well as caspase-1. Furthermore, Cdt-mediated inflammasome activa-

LDH (9%) in the presence of 200 ng/mL Cdt. In contrast, macrophages

tion was found to be dependent upon upstream danger signals includ-

derived from THP-1Syk- cells exhibited significantly less LDH (3.8%) in

ing: reactive oxygen species (ROS) and Cdt-induced increases in

Syk-

the cell supernatants. Similarly, THP-1

-derived macrophages failed

extracellular ATP. The latter contributed to the activation of the P2X7
purinergic receptor and K+ efflux. Additionally, we have demonstrated

to release significant amounts of HMGB1 (Figure 3b).
In the next series of experiments the requirement for Syk in medi-

that induction of this pro-inflammatory response was dependent upon

ating Cdt-induced caspase-4 activation was assessed. As shown in

CdtB associated PIP3 phosphatase activity. Specifically, enzymatic

WT

Figure 5f, THP-1

-derived macrophages cells exhibited an increase

depletion of PIP3 results in blockade of the PI-3K signalling pathway

in caspase-4 activity in the presence of Cdt (net OD405): 0.13 ± 0.006

leading to both Akt inactivation and GSK3β activation (Shenker et al.,

(0 Cdt), 0.18 ± 0.005 (200 ng/mL Cdt) and 0.190 ± 0.009 (500 ng/mL

2016a). In the current study we demonstrate that, in addition to the

Cdt). In comparison, THP-1Syk- -derived macrophages did not exhibit

canonical inflammasome, the Cdt-induced pro-inflammatory response

an increase in caspase-4 activity over levels observed with control

is also dependent upon activation of the noncanonical inflammasome

cells.

and further that activation of both inflammasomes contribute to cyto-

In previous studies we

established that

the action of

A. actinomycetemcomitans Cdt on lymphocytes and macrophages was

kine release which is dependent upon GSDMD cleavage which in turn
leads to pyroptosis (summarised in Figure 7).

dependent upon CdtB's ability to function as a PIP3 phosphatase

Pyroptosis was first recognised as a form of cell death that was

(Shenker, Boesze-Battaglia et al., 2016; Shenker et al., 2007; Shenker

distinct from apoptosis as it was independent of caspase-3 (Tang,

et al., 2014). Depletion of PIP3 results in PI-3K signalling blockade:

Kang, Berghe, Vandenabeele, & Kroemer, 2019; Xia et al., 2019). The

reduced PIP3, reduced pAkt (loss of kinase activity) and reduced

two forms of cell death exhibit other distinguishing characteristics.

pGSK3β (activation of kinase activity). The significance of these obser-

Morphologically, pyroptotic cells display loss of plasma membrane

vations was demonstrated by the ability of GSK3β inhibitors to block

integrity which results from pore formation within the plasma mem-

Cdt

NLRP3

brane and ultimately leads to cell swelling and release of cytoplasmic

inflammasome (Shenker, Boesze-Battaglia et al., 2016; Shenker et al.,

content. Biochemically, pyroptosis is mediated by inflammatory

2014). In order to build upon our previous observations and link them

caspases-1, -4, -5 and -11 (murine cells) (Casson et al., 2015; Sol-

with our current studies, we next explored the possibility that the

lberger, Strittmatter, Kistowska, French, & Beer, 2012; Taabazuing

observed increases in Cdt-mediated Syk phosphorylation might also

et al., 2017; Tang et al., 2019; Vigano et al., 2015). As noted above,

be linked to PI-3K signalling. Therefore, we assessed the ability of two

caspase-1 is typically activated by a multi-protein complex, the

of these inhibitors, GSK-3 inhibitor X and XV, to block Cdt-induced

inflammasome, consisting of a NOD-like receptor (NLR), a linker pro-

increases in pSyk. As shown in Figure 6, both inhibitors reduced back-

tein such as ASC and pro-caspase-1 and is often referred to as the

ground levels of pSyk to: 25.4% (GSK-3 X) and 73.8% (GSK-3 XV) of

canonical inflammasome (He, Hara, & Nunez, 2016). Activation of the

toxicity

including

activation

of

the

canonical
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F I G U R E 7 Schematic showing an
overview of the proposed activation of
the noncanonical inflammasome and
pyroptosis by Cdt. Internalisation of
CdtB leads to activation of caspase-4
and caspase-1; the later involves
activation of the canonical
inflammasome that we have previously
described in detail (Shenker et al.,
2015). Both caspase-4 and caspase-1
cleave GSDMD to release the poreforming fragment, GSDMD-NT.
Initially, this leads to the formation of
small pores that facilitate the release
of IL-1β, IL-18 and HMGB1.
Eventually, these pores enlarge and
become lytic allowing LDH to escape
from the dying cells

canonical inflammasome leads to cleavage and activation of caspase-1

contrast, macrophages derived from either THP-1Casp1- or THP-1Casp4-

and, in turn, maturation of IL-1β. Cell death mediated by this complex

cells did not exhibit GSDMD cleavage or increased membrane perme-

is referred to as canonical pyroptosis and typically occurs in mono-

ability as evinced by the failure to release either LDH or HMGB1.

cytes, macrophages and dendritic cells (Russo, Behl, Banerjee, &

These results suggest that not only are these cells resistant to Cdt-

Rathinam, 2018; Shi et al., 2017). In contrast, noncanonical pyroptosis

induced pyroptosis but also that both caspase-1 and caspase-4 were

is mediated by activated caspases-4, -5, -11 and occurs in a variety of

required for this lytic form of cell death. These caspases are thought

cell types (Shi et al., 2017; Xia et al., 2019). Activation of this pathway

to act in a synergistic role in mediating GSDMD cleavage and in turn,

was initially identified as occurring as a result of direct interaction

pyroptosis. Therefore, it was surprising that depletion of either

between intracellular bacterial lipopolysaccharide (LPS) and caspase-

caspase-1 or caspase-4 was sufficient to block pyroptosis and IL-1β

4/5; cell surface interactions involving TLR4-LPS do not activate these

release. These results suggest a cooperative role such that the activa-

caspases (Shi et al., 2014). Whereas activated caspase-1 directly

tion of either caspase alone is insufficient to induce pyroptosis and

cleaves pro-IL-1β and pro-IL-18 leading to the formation of the

facilitate cytokine release or alternatively, that caspase-4 is upstream

mature cytokine, caspases -4, -5 and -11 do not promote cleavage.

of caspase-1.

However, each of these caspases, along with caspase-1, cleave

GSDMDs are a family of cytosolic proteins with diverse function

GSDMD releasing the active, pore forming, N-terminal fragment,

and expression profiles; one member of this family, GSDMD, as noted

GSDMD-NT (Evavold & Kagan, 2019; Feng, Fox, & Man, 2018a; Liu

above is cleaved by caspases-1 and -4. The liberated N-terminus,

et al., 2016; Shi et al., 2017).

GDSMD-NT, is the pore forming fragment (Evavold & Kagan, 2019;

We now demonstrate that in addition to caspase-1, caspase-4 is

Feng, Fox, & Man, 2018a; Liu et al., 2016; Shi et al., 2017). Indeed, we

activated in Cdt-treated macrophages and, further, the release of IL-

demonstrate that not only do Cdt-treated macrophages contain signif-

1β is also dependent upon caspase-4. Cells pre-treated with the

icant increases in GSDMD-NT when exposed to Cdt, but further, that

caspase-4 inhibitor LEVD-CHO or deficient in caspase-4 expression

NSA, an inhibitor of GSDMD cleavage, blocks the release of both IL-

were resistant to Cdt-induced cytokine release. Cdt-treated macro-

1β and LDH (Rathkey et al., 2018). Following cleavage, GSDMD-NT

phages become pyroptotic within 48 hr and exhibit both GSDMD

has been shown to bind to phosphatidylinositol (PI) phosphates on

cleavage and an increase in membrane permeability (Kovacs & Miao,

the inner leaf of plasma membranes as well as on mitochondrial, lyso-

2017; Sborgi et al., 2016; Shi et al., 2015). The latter was demon-

somal, phagocytic and endosomal membranes (reviewed in Feng,

strated by the release of both LDH and HMGB1 into culture superna-

Fox, & Man, 2018a). This interaction is critical to subsequent pore for-

tants. The release of HMGB1 is particularly significant as it not only

mation as it promotes oligomerization of GSDMD-NT. One of the

represents a marker for the onset of pyroptosis but is also a potent

phosphoinositides that GSDMD-NT binds to is PI-3,4-P2; this PI-

inducer of pro-inflammatory responses (Lotze & Tracey, 2005). In

disphosphate is of particular relevance to our study as it is the
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enzymatic breakdown product of CdtB-mediated PIP3 degradation

pathogen recognition receptors (PRRs) and further that activation of

(Shenker et al., 2007). Thus, it is interesting to speculate that a sec-

this tyrosine kinase has been shown to be critical for pro-

ondary effect of CdtB on macrophages is to not only induce PI-3K sig-

inflammatory cytokine gene expression (reviewed in Mocsai, Ruland, &

nalling blockade and activate the canonical and noncanonical

Tybulewicz, 2010). Additionally, canonical inflammasome activation

inflammasomes, but to further potentiate pore formation by providing

has been shown to be regulated by pSyk via phosphorylation of ASC,

additional docking sites for the GDSMD-NT. These potential interac-

a requirement for its oligomerization. Indeed, we demonstrate that

tions are the subject of ongoing investigation.

within 15 min of exposure to Cdt, there is a significant increase in

One critical feature of pores formed by GSDMD-NT is that they

pSyk. Moreover, pre-incubation of cells with Syk inhibitors blocks

are selective and further that selectivity is determined by pore size

Cdt-induced release of mature IL-1β. Similarly, macrophages derived

(Liu et al., 2016). Initially, the pores are small (10–15 nm inner diame-

from Syk deficient cells (THP-1Syk-) were resistant to Cdt-induced IL-

ter), large enough for the release of cytokines and the danger signal

1β release. These results are consistent with the reported role of Syk

HMGB1. This is critical for the release of mature IL-1β and IL18

in mediating activation of the NLRP3 inflammasome (Feng et al.,

(~4.5 nm diameter) which lack N-terminal signal sequences necessary

2018b; Fitzpatrick, 2015; Said-Sadier, Padilla, Langsley, & Ojcius,

for secretion via biosynthetic vesicle-mediated pathways. Further-

2010). We also observed that THP-1Syk--derived macrophages failed

more, it has been proposed that the formation of these small

to exhibit an increase in caspase-4 activity in the presence of Cdt and

GSDMD-NT-dependent pores is consistent with macrophages being

further that the toxin did not induce the release of either HMGB1 or

in a hyperactive/pro-inflammatory state (Evavold & Kagan, 2019).

LDH in these cells. Thus, in addition to canonical inflammasome acti-

Under these conditions the pores are not lytic and cells are able to

vation, Syk appears to also regulate Cdt-induced activation of the

survive. Our findings are consistent with this scheme as we observe

noncanonical inflammasome and ultimately pyroptosis.

the release of IL-β and HMGB1 during the first 24 hr of exposure to

In order to account for CdtB-dependent Syk activation, we

Cdt; we do not observe the release of LDH at this time. LDH requires

explored the possibility that GSK3β might be involved. As noted ear-

larger lytic pores to escape cells as it exists as a tetramer in the cyto-

lier, we have previously demonstrated that Cdt-induced PI-3K signal-

sol. Eventually, the pores enlarge and reach a threshold that leads to

ling blockade in both lymphocytes and macrophages results in GSK3β

the lytic phase of pyroptosis characterised by the release of LDH and

activation (Scuron et al., 2016; Shenker, Boesze-Battaglia et al., 2016;

other intracellular components (Evavold & Kagan, 2019; Shi et al.,

Shenker et al., 2007; Shenker et al., 2015; Shenker et al., 2014). More-

2017; Taabazuing et al., 2017). Indeed, we do not observe LDH

over, we have shown that GSK3β inhibitors blocked toxin-induced IL-

release in Cdt-treated cells until 48 post treatment with the toxin. The

1β release, clearly indicating a role for this kinase in canonical and/or

mechanism leading to transition to larger lytic pores is not clear, but it

noncanonical inflammasome activation. We now report that these

has been proposed that initially the number and/or size of the

same inhibitors block Cdt-induced Syk phosphorylation. These studies

GDSMD-NT pores is maintained by an endosomal sorting complex

demonstrate a potential link between GSK3β activation and/or a

required for transport (ESCRT)-III repair mechanism (Ruhl et al., 2018).

downstream PI-3K signalling component, Syk activation and IL-1β

It has been suggested that failure of this repair mechanism ultimately

release via canonical and/or noncanonical pathways.

contributes to pyroptotic cell death.

In conclusion, we propose that pyroptosis, in general, and Cdt-

Previously, we have detailed the relationship between CdtB asso-

induced pyroptosis, in particular, is critical to the toxins virulence

ciated lipid phosphatase activity, PI-3K signalling and Cdt toxicity and,

potential as this form of cell death has been implicated to play a criti-

as noted above, one of the key outcomes of this blockade is the acti-

cal role in microbial infection and host defence. One key aspect of this

vation of GSK3β (i.e., reduced phosphorylation). Thus, it is consistent

lytic cell death pathway is that it provides a mechanism for the release

that the ability of Cdt to activate canonical and noncanonical inflam-

of IL-1β and IL-18, cytokines that lack signal sequences for secretion,

masomes and thereby induce pyroptosis requires that the toxin com-

as well as other pro-inflammatory mediators such as HMGB1 and

plex contain a CdtB subunit that retains PIP3 phosphatase activity

eicosonaids (Figure 7). Collectively, these pro-inflammatory mediators

(e.g., CdtBWT or CdtBA163R). Likewise, it was not surprising that CdtB

potentially benefit the host by promoting microbial clearance through

mutants that lack lipid phosphatase and toxic activity (CdtBR117A and

both bactericidal and phagocytic mechanisms. In this context, it is also

R144A

) were unable to induce LDH and HMGB1 release as well as

important to note that in addition to creating pores in the plasma

activate caspase-4. These observations point to a potential linkage

membranes of host cells, GSDMD-NT is lethal to bacteria. Pyroptosis

between the induction of pyroptosis and CdtB-mediated blockade of

also serves to eliminate intracellular pathogens as host cell death

the PI-3K signalling pathway. The activation of this kinase and the

releases these organisms where they face elimination by both innate

potential cross-talk between PI-3K signalling and inflammasome acti-

and acquired host defence (Xia et al., 2019). Alternatively, pyroptotic

vation is further discussed below as it may also relate to Syk

amplification of the release of inflammatory mediators contributes to

activation.

development of chronic inflammation and tissue injury. It is in this

CdtB

Syk is a nonreceptor tyrosine kinase; its activation is typically con-

context that we propose that Cdt-hijacks this critical host defence

sidered to be the result of interaction with immunoreceptor tyrosine-

mechanism, amplifies the pro-inflammatory response and eventually

based motif (ITAM)-containing proteins. It is becoming increasingly

contributes to the destruction of tooth supporting tissue, a clinical

clear that Syk is activated in macrophages following stimulation via

feature

of

A.

actinomycetemcomitans

infection.

Moreover,
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A. actinomycetemcomitans Cdt is capable of functioning as a tri-

containing 10% fetal bovine serum and 2% penicillin/streptomycin

perditious toxin (virulence factor) by altering host defence mecha-

for 6–8 days.

nisms where it impairs acquired immunity, activates innate immunity

THP-1 derived macrophages and MDM were incubated as

and damages epithelial barriers (reviewed in Scuron et al., 2016).

described below (or in Figure legends) and treated with recombinant

These properties are consistent with the current view of the role for

Cdt holotoxin containing CdtB wildtype (CdtBWT) or mutant

A. actinomycetemcomitans in the pathogenesis of localised aggressive

(CdtBA163R, CdtBR117A or CdtBR144A) which were expressed and puri-

periodontitis. Rather than serve as the causative agent, it has been

fied as described below. In some experiments cells were also treated

proposed that A. actinomycetemcomitans is an early coloniser that

with:

modifies local host defence; this perturbation facilitates both its own

picceatanol, GSK inhibitor XV (MilliporeSigma, Burlington, MA) and

survival and in turn contributes to dysbiosis by advancing the survival

GSK inhibitor X (Santa Cruz Biotechnology, Dallas, TX).

necrosulfonamide

(NSA),

Syk

inhibitor

II,

Bay61-3606,

of other microbes (Fine, Patil, & Velusamy, 2019). The ability to function in this manner and differentially affect a spectrum of cell types is
due to two properties of this AB2 toxin. The binding unit, CdtC, binds

4.2

|

Expression and purification of Cdt holotoxin

to cholesterol, a ubiquitous component of all cell membranes and the
active subunit, CdB, is a lipid phosphatase capable of depleting cells

Construction and expression of the plasmid containing the cdt genes

of PIP3 resulting in blockade of the PI-3K signalling pathway, a ubiqui-

for the holotoxin (pUCAacdtABChis) have previously been reported

tous signalling cascade, functional in all cells.

(Shenker et al., 2004). The plasmids were constructed so that the cdt
genes were under control of the lac promotor and transformed into
E. coli DH5α. Cultures of transformed E. coli were grown in 1 L LB

4

E X P E R I M E N T A L P R O C E D U RE S

|

broth and induced with 0.1 mM IPTG for 2 hr; bacterial cells were
harvested, washed and resuspended in 50 mM Tris (pH 8.0). The cells

4.1

|

Cells and reagents

were frozen overnight, thawed and sonicated. The histidine-tagged
peptide holotoxin was isolated by nickel affinity chromatography as

The human acute monocytic leukaemia cell line, THP-1, was obtained

previously described (Shenker et al., 2004).

from ATCC; cells were maintained in RPMI 1640 containing 10% FBS,
1 mM sodium pyruvate, 20 μM 2-mercaptoethanol and 2% penicillin–
streptomycin at 37 C with 5% CO2 in a humidified incubator. THP-1

4.3

|

Analysis of IL-1β release

cells stably expressing shRNA against caspase-1 (THP-1Casp1-) and Syk
(THP-1Syk-) were provided by D. M. Ojcius and previously described

IL-1β release was measured in THP-1 derived macrophages (2 × 105

(Abdul-Sater, Said-Sadier, Padilla, & Ojcius, 2010; Chen et al., 2012);

cells) or MDM incubated for 5 hr in the presence or absence of vary-

Casp4-

caspase-4 deficient cells (THP-1

) were provided by P.R. Huang

ing amounts of Cdt as previously described (Shenker et al., 2015).

and similarly prepared with lentiviral particles containing the following

Briefly, culture supernatants were collected and analysed by ELISA for

sequence:5-0 -GCAACGTATGGCAGGACAAAT-300 . The cells were pre-

IL-1β (Quantikine Elisa Kit; R and D Systems, Minneapolis, MN). In

pared by transducing THP-1 cells with lentiviral particles, along with

each instance, the amount of cytokine present in the supernatant was

nontarget controls, as previously described (Abdul-Sater et al., 2010;

determined using a standard curve.

Chen et al., 2012). Expression levels were recently reported to be
reduced >95% for THP-1Casp1-, >70% THP-1Syk- and caspase-4 was
not detectable by Western blot in THP-1Casp4 cells with no effect in

4.4

|

Western blot analysis

the nontarget controls (Zhu et al., 2015). THP-1 cells were differentiated into macrophages by incubating cells in the presence of 50 ng/

Replicate wells of THP-1 derived macrophages (4 × 106 cells/well)

mL PMA for 48 hr at which time the cells were washed and incubated

were incubated as described with Cdt. The cells were washed and

an additional 24 hr in medium prior to use.

treated with 20 mM Tris–HCl buffer (pH 7.5) containing 150 mM

Human peripheral blood mononuclear cells (HPBMC) were

NaCl, 1 mM EDTA, 1% NP-40, 1% sodium deoxycholate and protease

obtained from venous blood of healthy donors as previously

and phosphatase inhibitors (ThermoFisher Pierce Protein Biology,

described (Shenker et al., 2004). Monocytes were further purified

Pittsburgh, PA); replicate wells were pooled and protein concentration

from HPBMC by positive selection using anti-CD14 mAb according

determined. HMGB1 release into culture supernatants was deter-

to the manufacturers directions (Dynabeads

®

FlowComp™ Human

mined following precipitation of supernatants in 20% TCA. Samples

CD14; ThermoFisher Invitrogen, Waltham, MA). Anti-CD14 mAb-

were separated on 12% SDS-PAGE and then transferred to nitrocellu-

bead complexes were removed from the positively selected mono-

lose. The membrane was blocked with BLOTTO and then incubated

cytes using a release buffer (Invitrogen). Monocytes were routinely

with anti-pro-IL-1β, anti-caspase-4, anti-Syk, anti-pSyk, anti-GSDMD

found to be >96% pure as determined by immunofluorescent

or anti-GAPDH antibody (Santa Cruz Biotechnology) for 18 hr at 4 C

staining and analysed by flow cytometry. Monocyte-derived macro-

(Shenker et al., 1999). Membranes were washed, incubated with

phages (MDM) were generated by incubating monocytes in DMEM

either goat anti-rabbit IgG or goat-anti-mouse IgG conjugated to
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horseradish peroxidase. The Western blots were developed using
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Analysis of LDH release

THP-1-derived macrophages (5 × 104) were incubated as described in
Figure Legends. The supernatants were harvested and LDH activity
was detected using a commercially available kit (LDH Cytotoxicity
Assay Kit; ThermoFisher Pierce Protein Biology). Extracellular LDH in
the supernatant was quantified by a coupled enzymatic reaction in
which LDH catalyses the conversion of lactate to pyruvate via NAD+
reduction to NADH. NADH is then utilised by diaphorase to reduce
tetrazolium salt to red formazan which is measured at OD490
nm. LDH release is presented as % net LDH release: 100× (experimental

OD490

release-spontaneous

OD490

release/maximum

OD490 release-spontaneous OD490 release).
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|

Analysis of caspase-4 activity

THP-1-derived macrophages (4 × 106) were incubated as described in
the figure legends. Caspase-4 activity was measured using a commercially available kit (Caspase-4 Colorimetric Assay Kit; BioVision, Milpitas, CA). Cells were harvested, lysed and following centrifugation the
supernatants containing the cytosolic extract were assessed for
caspase-4 activity. Briefly, caspase-4 activity was determined by monitoring the release of the chromophore p-nitranilide (pNA) from the
labelled substrate, LEVD-pNA at OD405 nm. Background OD405 from
cell lysates and buffers were subtracted from measurements obtained
from both control and treated samples (net OD405).
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|

Statistical analysis

Mean ± standard error of the mean were calculated for replicate
experiments. Significance was determined using a Student's t-test; differences between multiple treatments were compared by ANOVA
paired with Tukeys HSD posttest; a P-value of less than .05 was considered to be statistically significant.
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